Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Trans-sodium crocetinate for treating hypoxia/ischemia.

Gainer JL.

Expert Opin Investig Drugs. 2008 Jun;17(6):917-24. doi: 10.1517/13543784.17.6.917 . Review.

PMID:
18491992
2.

Trans-sodium crocetinate and hemorrhagic shock.

Stennett AK, Murray RJ, Roy JW, Gainer JL.

Shock. 2007 Sep;28(3):339-44.

PMID:
17545940
3.

TSC for hemorrhagic shock: effects on cytokines and blood pressure.

Stennett AK, Gainer JL.

Shock. 2004 Dec;22(6):569-74.

PMID:
15545830
4.

Trans-sodium crocetinate restores blood pressure, heart rate, and plasma lactate after hemorrhagic shock.

Giassi LJ, Gilchrist MJ, Graham MC, Gainer JL.

J Trauma. 2001 Nov;51(5):932-8.

PMID:
11706343
5.

trans-Sodium crocetinate and diffusion enhancement.

Stennett AK, Dempsey GL, Gainer JL.

J Phys Chem B. 2006 Sep 21;110(37):18078-80.

PMID:
16970413
6.

Trans-sodium crocetinate increases oxygen delivery to brain parenchyma in rats on oxygen supplementation.

Okonkwo DO, Wagner J, Melon DE, Alden T, Stone JR, Helm GA, Jane JA Sr.

Neurosci Lett. 2003 Dec 4;352(2):97-100.

PMID:
14625032
7.

TSC and hemorrhagic shock.

Giassi LJ, Gainer JL.

Adv Exp Med Biol. 2003;540:55-60. Review. No abstract available.

PMID:
15174602
8.

Trans-sodium crocetinate does not affect oxygen uptake in rats during treadmill running.

Kemi OJ, Ellingsen O.

Scand J Clin Lab Invest. 2005;65(7):577-84.

PMID:
16271989
9.

Trans-sodium crocetinate improves outcomes in rodent models of occlusive and hemorrhagic stroke.

Wang Y, Yoshimura R, Manabe H, Schretter C, Clarke R, Cai Y, Fitzgerald M, Lee KS.

Brain Res. 2014 Oct 2;1583:245-54. doi: 10.1016/j.brainres.2014.08.013. Epub 2014 Aug 14.

10.

Trans sodium crocetinate: functional neuroimaging studies in a hypoxic brain tumor.

Sheehan JP, Popp B, Monteith S, Toulmin S, Tomlinson J, Martin J, Cifarelli CP, Lee DH, Park DM.

J Neurosurg. 2011 Oct;115(4):749-53. doi: 10.3171/2011.5.JNS101954. Epub 2011 Jun 17.

PMID:
21682571
11.

Metabolic reflow as a therapy for ischemic brain injury.

Manabe H, Wang Y, Yoshimura R, Cai Y, Fitzgerald M, Clarke R, Lee KS.

Acta Neurochir Suppl. 2011;110(Pt 2):87-91. doi: 10.1007/978-3-7091-0356-2_16.

PMID:
21125451
12.

Sodium crocetinate does not alter gut hypercapnic responses or renal energy stores during transient sub-diaphragmatic ischaemia.

Morgan TJ, Venkatesh B, Crerar-Gilbert A, Willgoss D, Endre ZH.

Intensive Care Med. 2003 Apr;29(4):652-4. Epub 2003 Feb 8.

PMID:
12577154
13.

No effect of trans sodium crocetinate on maximal O(2) conductance or V(O(2),max) in moderate hypoxia.

Hepple RT, Stary CM, Kohin S, Wagner PD, Hogan MC.

Respir Physiol Neurobiol. 2003 Mar 28;134(3):239-46.

PMID:
12660103
14.

The effect of crocetin on hemorrhagic shock in rats.

Gainer JL, Rudolph DB, Caraway DL.

Circ Shock. 1993 Sep;41(1):1-7.

PMID:
8403242
15.

Perihematomal Cellular Injury Is Reduced by Trans-sodium Crocetinate in a Model of Intracerebral Hemorrhage.

Wang Y, Schretter C, Clarke R, Lee KS.

Mol Neurobiol. 2015 Oct;52(2):985-9. doi: 10.1007/s12035-015-9245-8. Epub 2015 Jun 7.

PMID:
26050085
16.

Effect of trans sodium crocetinate on brain tumor oxygenation. Laboratory investigation.

Sheehan J, Sherman J, Cifarelli C, Jagannathan J, Dassoulas K, Olson C, Rainey J, Han S.

J Neurosurg. 2009 Aug;111(2):226-9. doi: 10.3171/2009.3.JNS081339.

PMID:
19326986
17.

[Characteristics of the antihypoxic action of piracetam].

Gukasov VM, Rasulov MM, Efuni SN, Kaplan EIa, Smiriagina VI.

Biull Eksp Biol Med. 1987 Jun;103(6):683-5. Russian.

PMID:
3593950
18.
19.

The effect of trans sodium crocetinate (TSC) in a rat oleic acid model of acute lung injury.

Gainer JL, Stennett AK, Murray RJ.

Pulm Pharmacol Ther. 2005;18(3):213-6. Epub 2005 Jan 22.

PMID:
15707856
20.
Items per page

Supplemental Content

Write to the Help Desk